← Back to catalogue

Ingenia

FDA UDI

Class II (US FDA UDI)

by Philips Medical Systems Nederland B.V.

Identity

Trade Name
Ingenia FDA UDI
Generic Name
Full-body MRI system, superconducting magnet FDA UDI
Device Name
The Ingenia Elition X with the gradient and RF designs, as well as Compressed SENSE delivers on superb image quality, improves patient handling setup time and combines this with accelerations in both 2D- and 3D scanning. FDA UDI
Model / Reference
Ingenia Elition X FDA UDI
Description
The Ingenia Elition X with the gradient and RF designs, as well as Compressed SENSE delivers on superb image quality, improves patient handling setup time and combines this with accelerations in both 2D- and 3D scanning. FDA UDI

Identifiers

Catalog Number
782119 FDA UDI
Primary DI / UDI-DI
00884838104129 FDA UDI
510(k) Number
K213516 FDA UDI
FDA Product Code
LNH FDA UDI
GMDN Term
Full-body MRI system, superconducting magnet FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
892.1000 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Full-body MRI system, superconducting magnet

Ingenia by Philips Medical Systems Nederland B.V. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Full-body MRI system, superconducting magnet.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI a53b9065-5d7d-4b9f-9ce5-2f3441a2d9da 36 fields · synced Sep 18, 2026